

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 9.83930698 |
| 2 | Fc-gamma receptor signaling pathway (GO:0038094) | 9.83930698 |
| 3 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 9.83930698 |
| 4 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 9.71088061 |
| 5 | glomerular filtration (GO:0003094) | 8.74405142 |
| 6 | retina homeostasis (GO:0001895) | 8.67382735 |
| 7 | humoral immune response (GO:0006959) | 8.00959645 |
| 8 | renal filtration (GO:0097205) | 7.94212682 |
| 9 | regulation of respiratory burst (GO:0060263) | 6.50956397 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 6.27723731 |
| 11 | negative regulation of B cell proliferation (GO:0030889) | 6.21875792 |
| 12 | B cell receptor signaling pathway (GO:0050853) | 5.90723281 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.85297353 |
| 14 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.73868679 |
| 15 | negative regulation of glucose import (GO:0046325) | 5.58325822 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.50262708 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.50262708 |
| 18 | regulation of B cell differentiation (GO:0045577) | 5.23124269 |
| 19 | L-fucose catabolic process (GO:0042355) | 4.87653198 |
| 20 | fucose catabolic process (GO:0019317) | 4.87653198 |
| 21 | L-fucose metabolic process (GO:0042354) | 4.87653198 |
| 22 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.85484360 |
| 23 | signal peptide processing (GO:0006465) | 4.77084050 |
| 24 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.71665599 |
| 25 | positive regulation of Rho protein signal transduction (GO:0035025) | 4.63920163 |
| 26 | negative regulation of glucose transport (GO:0010829) | 4.56215988 |
| 27 | regulation of B cell proliferation (GO:0030888) | 4.49903030 |
| 28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.45637278 |
| 29 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.39825146 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.27174419 |
| 31 | cellular response to zinc ion (GO:0071294) | 4.26247229 |
| 32 | Fc receptor signaling pathway (GO:0038093) | 4.14760536 |
| 33 | Fc-epsilon receptor signaling pathway (GO:0038095) | 4.10604311 |
| 34 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.98966491 |
| 35 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.90502873 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.87554976 |
| 37 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.77972378 |
| 38 | immune response-activating signal transduction (GO:0002757) | 3.77796487 |
| 39 | detection of other organism (GO:0098543) | 3.75601068 |
| 40 | detection of bacterium (GO:0016045) | 3.70145699 |
| 41 | chronic inflammatory response (GO:0002544) | 3.62712017 |
| 42 | germinal center formation (GO:0002467) | 3.60793855 |
| 43 | regulation of cellular extravasation (GO:0002691) | 3.56161809 |
| 44 | positive regulation of Rap GTPase activity (GO:0032854) | 3.51270211 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.48821227 |
| 46 | mannose metabolic process (GO:0006013) | 3.43726120 |
| 47 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.42917192 |
| 48 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.42492971 |
| 49 | activation of immune response (GO:0002253) | 3.40060242 |
| 50 | peptidyl-asparagine modification (GO:0018196) | 3.39464441 |
| 51 | protein-chromophore linkage (GO:0018298) | 3.38773448 |
| 52 | positive regulation of immunoglobulin production (GO:0002639) | 3.37503466 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36489059 |
| 54 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.32544394 |
| 55 | antibacterial humoral response (GO:0019731) | 3.32471195 |
| 56 | positive regulation of nuclease activity (GO:0032075) | 3.26492550 |
| 57 | N-acetylneuraminate metabolic process (GO:0006054) | 3.25308014 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.23598092 |
| 59 | wound healing, spreading of epidermal cells (GO:0035313) | 3.23118497 |
| 60 | B cell proliferation (GO:0042100) | 3.19845730 |
| 61 | regulation of B cell activation (GO:0050864) | 3.18324082 |
| 62 | antimicrobial humoral response (GO:0019730) | 3.15399509 |
| 63 | protein N-linked glycosylation (GO:0006487) | 3.15307885 |
| 64 | maternal placenta development (GO:0001893) | 3.14501986 |
| 65 | surfactant homeostasis (GO:0043129) | 3.14135036 |
| 66 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.12469089 |
| 67 | negative regulation of B cell activation (GO:0050869) | 3.11743259 |
| 68 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.11624604 |
| 69 | negative regulation of osteoclast differentiation (GO:0045671) | 3.11446321 |
| 70 | regulation of nuclease activity (GO:0032069) | 3.10688715 |
| 71 | negative thymic T cell selection (GO:0045060) | 3.09745860 |
| 72 | bone resorption (GO:0045453) | 3.07065173 |
| 73 | mature B cell differentiation (GO:0002335) | 3.04327839 |
| 74 | serine transport (GO:0032329) | 3.04317482 |
| 75 | cellular response to unfolded protein (GO:0034620) | 3.03540921 |
| 76 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.01616462 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01559938 |
| 78 | intestinal epithelial cell development (GO:0060576) | 3.01026254 |
| 79 | type I interferon signaling pathway (GO:0060337) | 3.00230213 |
| 80 | cellular response to type I interferon (GO:0071357) | 3.00230213 |
| 81 | complement activation, classical pathway (GO:0006958) | 21.7563067 |
| 82 | response to type I interferon (GO:0034340) | 2.98772636 |
| 83 | regulation of integrin activation (GO:0033623) | 2.97898295 |
| 84 | regulation of gamma-delta T cell activation (GO:0046643) | 2.97849999 |
| 85 | negative regulation of myotube differentiation (GO:0010832) | 2.97756088 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 2.96024843 |
| 87 | detection of external biotic stimulus (GO:0098581) | 2.95719939 |
| 88 | regulation of Rap GTPase activity (GO:0032317) | 2.95156989 |
| 89 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94261858 |
| 90 | positive regulation of histone deacetylation (GO:0031065) | 2.93499764 |
| 91 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.92734558 |
| 92 | cellular extravasation (GO:0045123) | 2.92647499 |
| 93 | Golgi transport vesicle coating (GO:0048200) | 2.91774219 |
| 94 | COPI coating of Golgi vesicle (GO:0048205) | 2.91774219 |
| 95 | negative regulation of complement activation (GO:0045916) | 2.90035220 |
| 96 | L-serine transport (GO:0015825) | 2.90030972 |
| 97 | B cell homeostasis (GO:0001782) | 2.90023524 |
| 98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.86439209 |
| 99 | N-glycan processing (GO:0006491) | 2.82832380 |
| 100 | sialylation (GO:0097503) | 2.82324396 |
| 101 | negative T cell selection (GO:0043383) | 2.79968607 |
| 102 | phenylpropanoid metabolic process (GO:0009698) | 2.78335452 |
| 103 | regulation of superoxide anion generation (GO:0032928) | 2.77935214 |
| 104 | ER-nucleus signaling pathway (GO:0006984) | 2.77197008 |
| 105 | cellular response to topologically incorrect protein (GO:0035967) | 2.74081223 |
| 106 | defense response to Gram-negative bacterium (GO:0050829) | 2.70427860 |
| 107 | respiratory burst (GO:0045730) | 2.68082313 |
| 108 | positive regulation of B cell activation (GO:0050871) | 2.67415015 |
| 109 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67192536 |
| 110 | production of molecular mediator of immune response (GO:0002440) | 2.66344272 |
| 111 | eosinophil chemotaxis (GO:0048245) | 2.65770704 |
| 112 | eosinophil migration (GO:0072677) | 2.64073702 |
| 113 | negative regulation of humoral immune response (GO:0002921) | 2.62597288 |
| 114 | B cell mediated immunity (GO:0019724) | 2.61831899 |
| 115 | thymic T cell selection (GO:0045061) | 2.61829567 |
| 116 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.60978341 |
| 117 | response to endoplasmic reticulum stress (GO:0034976) | 2.59484887 |
| 118 | cellular response to interferon-gamma (GO:0071346) | 2.59336849 |
| 119 | tissue homeostasis (GO:0001894) | 2.56560818 |
| 120 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.55659669 |
| 121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.55272897 |
| 122 | proline biosynthetic process (GO:0006561) | 2.54617434 |
| 123 | response to interleukin-15 (GO:0070672) | 2.54242978 |
| 124 | detection of biotic stimulus (GO:0009595) | 2.53148755 |
| 125 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.52917319 |
| 126 | negative regulation of protein activation cascade (GO:2000258) | 2.52811233 |
| 127 | positive thymic T cell selection (GO:0045059) | 2.52422101 |
| 128 | B cell activation (GO:0042113) | 2.51759321 |
| 129 | neutrophil activation (GO:0042119) | 2.51046595 |
| 130 | lymphocyte homeostasis (GO:0002260) | 2.50458162 |
| 131 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.49415396 |
| 132 | negative regulation of cell killing (GO:0031342) | 2.49415396 |
| 133 | natural killer cell differentiation (GO:0001779) | 2.49177033 |
| 134 | interferon-gamma secretion (GO:0072643) | 2.48377150 |
| 135 | dendritic cell chemotaxis (GO:0002407) | 2.44683812 |
| 136 | regulation of regulatory T cell differentiation (GO:0045589) | 2.44464765 |
| 137 | response to interferon-gamma (GO:0034341) | 2.44153049 |
| 138 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.42870904 |
| 139 | T-helper 1 type immune response (GO:0042088) | 2.39945775 |
| 140 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.38752083 |
| 141 | positive regulation of response to oxidative stress (GO:1902884) | 2.38752083 |
| 142 | positive regulation of type 2 immune response (GO:0002830) | 2.35658804 |
| 143 | regulation of macrophage chemotaxis (GO:0010758) | 2.34375763 |
| 144 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.34234161 |
| 145 | wound healing, spreading of cells (GO:0044319) | 2.32862777 |
| 146 | regulation of T cell tolerance induction (GO:0002664) | 2.32234893 |
| 147 | establishment of skin barrier (GO:0061436) | 2.30987881 |
| 148 | negative regulation of bone resorption (GO:0045779) | 2.29536032 |
| 149 | regulation of monocyte chemotaxis (GO:0090025) | 2.29506775 |
| 150 | regulation of water loss via skin (GO:0033561) | 2.29352053 |
| 151 | regulation of necrotic cell death (GO:0010939) | 2.28220528 |
| 152 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.24680310 |
| 153 | negative regulation of interleukin-12 production (GO:0032695) | 2.23097663 |
| 154 | regulation of chemokine secretion (GO:0090196) | 2.22911700 |
| 155 | positive regulation of T cell migration (GO:2000406) | 2.21742601 |
| 156 | defense response to protozoan (GO:0042832) | 2.20848884 |
| 157 | regulation of tolerance induction (GO:0002643) | 2.20630476 |
| 158 | lymphocyte chemotaxis (GO:0048247) | 2.20220573 |
| 159 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.20042180 |
| 160 | positive regulation of chemokine secretion (GO:0090197) | 2.19326622 |
| 161 | regulation of T cell migration (GO:2000404) | 2.19173507 |
| 162 | positive regulation of receptor recycling (GO:0001921) | 2.18198036 |
| 163 | multicellular organismal water homeostasis (GO:0050891) | 2.16691971 |
| 164 | detection of molecule of bacterial origin (GO:0032490) | 2.16510976 |
| 165 | neutrophil activation involved in immune response (GO:0002283) | 2.16177811 |
| 166 | complement activation (GO:0006956) | 16.6530235 |
| 167 | protein activation cascade (GO:0072376) | 10.7668430 |
| 168 | positive regulation of respiratory burst (GO:0060267) | 10.1801733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.19725975 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.24318526 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.13849689 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.65474277 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.55729334 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.32312958 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 4.29255465 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.22249929 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.94487584 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.83714263 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.70809240 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.66035112 |
| 13 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.45926119 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.44147378 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.32599205 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.01918087 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.98067430 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.90719195 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.71170434 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.56014782 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.48951393 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.47186414 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44857801 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26431459 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21701945 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.18014105 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17036413 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.13686984 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10705611 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.07956149 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.07801416 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07008697 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05895437 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.02574455 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01384803 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00693793 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.99167266 |
| 38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.97725654 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97437166 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97213114 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83217929 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82886772 |
| 43 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.80663275 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.80459492 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76928658 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.73567589 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71079969 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70874012 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.68260472 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67957527 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62893135 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55971206 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54307701 |
| 54 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.52031183 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.49608630 |
| 56 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49179449 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47530954 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47122806 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.44930446 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.44825026 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42953900 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42653777 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41978383 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40225708 |
| 65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39647929 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.38821906 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36547276 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35794717 |
| 69 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35562953 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34334845 |
| 71 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.30015668 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29656468 |
| 73 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28672461 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25420456 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25143924 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25053048 |
| 77 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.22143748 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21311311 |
| 79 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19674960 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18055971 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16415654 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15758387 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15703345 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15487145 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13556344 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13324673 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09909314 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09750754 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09315387 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09133247 |
| 91 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07146789 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05674246 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04744895 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04164197 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03727959 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03476567 |
| 97 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02506330 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02130736 |
| 99 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01339588 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00686147 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99201208 |
| 102 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98882551 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98513574 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96906291 |
| 105 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95644790 |
| 106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93387649 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92896374 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92353493 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92258577 |
| 110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90583626 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89043499 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88796953 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87304808 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86668300 |
| 115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86668300 |
| 116 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84700088 |
| 117 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.83882560 |
| 118 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83643255 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83577467 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83241615 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83024858 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83024858 |
| 123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82987293 |
| 124 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.82888524 |
| 125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.82757990 |
| 126 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82093790 |
| 127 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81949071 |
| 128 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.81629962 |
| 129 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81619525 |
| 130 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81004576 |
| 131 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.79432701 |
| 132 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79092997 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78535965 |
| 134 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77265142 |
| 135 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75333277 |
| 136 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75188016 |
| 137 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74012082 |
| 138 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73662585 |
| 139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73098339 |
| 140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71784784 |
| 141 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.71472263 |
| 142 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71127333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.31409489 |
| 2 | MP0003724_increased_susceptibility_to | 5.21846008 |
| 3 | MP0001800_abnormal_humoral_immune | 4.78095852 |
| 4 | MP0003303_peritoneal_inflammation | 4.55855099 |
| 5 | MP0001790_abnormal_immune_system | 3.66962311 |
| 6 | MP0005387_immune_system_phenotype | 3.66962311 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.51811278 |
| 8 | MP0005671_abnormal_response_to | 3.19121324 |
| 9 | MP0002723_abnormal_immune_serum | 2.95355305 |
| 10 | MP0005275_abnormal_skin_tensile | 2.90353647 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.84666436 |
| 12 | MP0002398_abnormal_bone_marrow | 2.82741240 |
| 13 | MP0001819_abnormal_immune_cell | 2.79796418 |
| 14 | MP0000685_abnormal_immune_system | 2.72441575 |
| 15 | MP0000716_abnormal_immune_system | 2.68348890 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.63588914 |
| 17 | MP0001879_abnormal_lymphatic_vessel | 2.48699770 |
| 18 | MP0006054_spinal_hemorrhage | 2.46268931 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.45852909 |
| 20 | MP0000689_abnormal_spleen_morphology | 2.39142681 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.37408464 |
| 22 | MP0004264_abnormal_extraembryonic_tissu | 2.24041193 |
| 23 | MP0005025_abnormal_response_to | 2.23128205 |
| 24 | MP0002429_abnormal_blood_cell | 2.21654141 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.18177998 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 2.11608398 |
| 27 | MP0003436_decreased_susceptibility_to | 2.03908707 |
| 28 | MP0002722_abnormal_immune_system | 2.00204788 |
| 29 | MP0002419_abnormal_innate_immunity | 1.96057849 |
| 30 | MP0005166_decreased_susceptibility_to | 1.95092262 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.92648538 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.90897781 |
| 33 | MP0002006_tumorigenesis | 1.87532218 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.83666627 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.83272035 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.78118407 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.75540540 |
| 38 | MP0004947_skin_inflammation | 1.72425221 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.72195724 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.69726331 |
| 41 | MP0005503_abnormal_tendon_morphology | 1.65109464 |
| 42 | MP0008004_abnormal_stomach_pH | 1.60963155 |
| 43 | MP0005023_abnormal_wound_healing | 1.57237072 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.54118115 |
| 45 | MP0002405_respiratory_system_inflammati | 1.51429653 |
| 46 | MP0003448_altered_tumor_morphology | 1.50844802 |
| 47 | MP0003279_aneurysm | 1.46837965 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.43315919 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.42900024 |
| 50 | MP0002796_impaired_skin_barrier | 1.41836958 |
| 51 | MP0003045_fibrosis | 1.40530389 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.39824413 |
| 53 | MP0000343_altered_response_to | 1.38810661 |
| 54 | MP0009785_altered_susceptibility_to | 1.38005264 |
| 55 | MP0000858_altered_metastatic_potential | 1.28527214 |
| 56 | MP0001873_stomach_inflammation | 1.25251498 |
| 57 | MP0005164_abnormal_response_to | 1.23285667 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.22109764 |
| 59 | MP0005390_skeleton_phenotype | 1.22076038 |
| 60 | MP0001851_eye_inflammation | 1.20695863 |
| 61 | MP0009764_decreased_sensitivity_to | 1.20681922 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.20408223 |
| 63 | MP0002019_abnormal_tumor_incidence | 1.20047550 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.17926833 |
| 65 | MP0003828_pulmonary_edema | 1.17429628 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.16707631 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 1.15604076 |
| 68 | MP0005310_abnormal_salivary_gland | 1.15032359 |
| 69 | MP0006082_CNS_inflammation | 1.12037741 |
| 70 | MP0008057_abnormal_DNA_replication | 1.08572425 |
| 71 | MP0002060_abnormal_skin_morphology | 1.08375239 |
| 72 | MP0000490_abnormal_crypts_of | 1.08258673 |
| 73 | MP0002933_joint_inflammation | 1.07706079 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.05950641 |
| 75 | MP0009278_abnormal_bone_marrow | 1.05063032 |
| 76 | MP0003866_abnormal_defecation | 1.04651044 |
| 77 | MP0008961_abnormal_basal_metabolism | 1.04406333 |
| 78 | MP0002877_abnormal_melanocyte_morpholog | 1.04360845 |
| 79 | MP0004858_abnormal_nervous_system | 1.03663896 |
| 80 | MP0001542_abnormal_bone_strength | 1.01223802 |
| 81 | MP0010678_abnormal_skin_adnexa | 1.00831362 |
| 82 | MP0005381_digestive/alimentary_phenotyp | 0.98871199 |
| 83 | MP0000920_abnormal_myelination | 0.96500213 |
| 84 | MP0010368_abnormal_lymphatic_system | 0.95970202 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.95659728 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.95374453 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.95374453 |
| 88 | MP0008569_lethality_at_weaning | 0.93739786 |
| 89 | MP0004147_increased_porphyrin_level | 0.91966472 |
| 90 | MP0008872_abnormal_physiological_respon | 0.91583747 |
| 91 | MP0000249_abnormal_blood_vessel | 0.90766684 |
| 92 | MP0001853_heart_inflammation | 0.90503692 |
| 93 | MP0004510_myositis | 0.88528760 |
| 94 | MP0001216_abnormal_epidermal_layer | 0.87925416 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.86692406 |
| 96 | MP0000681_abnormal_thyroid_gland | 0.86384516 |
| 97 | MP0005165_increased_susceptibility_to | 0.83677100 |
| 98 | MP0003868_abnormal_feces_composition | 0.83406752 |
| 99 | MP0000003_abnormal_adipose_tissue | 0.83350601 |
| 100 | MP0008469_abnormal_protein_level | 0.83114669 |
| 101 | MP0001663_abnormal_digestive_system | 0.83068965 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.82657471 |
| 103 | MP0000733_abnormal_muscle_development | 0.81629154 |
| 104 | MP0003795_abnormal_bone_structure | 0.80944171 |
| 105 | MP0000579_abnormal_nail_morphology | 0.80900455 |
| 106 | MP0002139_abnormal_hepatobiliary_system | 0.80700669 |
| 107 | MP0001533_abnormal_skeleton_physiology | 0.79303561 |
| 108 | MP0005360_urolithiasis | 0.77537772 |
| 109 | MP0001664_abnormal_digestion | 0.75245018 |
| 110 | MP0002168_other_aberrant_phenotype | 0.74611066 |
| 111 | MP0000609_abnormal_liver_physiology | 0.73783211 |
| 112 | MP0003690_abnormal_glial_cell | 0.73151677 |
| 113 | MP0002098_abnormal_vibrissa_morphology | 0.72314741 |
| 114 | MP0001919_abnormal_reproductive_system | 0.71570898 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.70741999 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.68822132 |
| 117 | MP0003075_altered_response_to | 0.65522213 |
| 118 | MP0002133_abnormal_respiratory_system | 0.65323399 |
| 119 | MP0005388_respiratory_system_phenotype | 0.65323399 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.65094692 |
| 121 | MP0009046_muscle_twitch | 0.64728077 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.64195603 |
| 123 | MP0002083_premature_death | 0.64114326 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.63214957 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.62035354 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61853018 |
| 127 | MP0001944_abnormal_pancreas_morphology | 0.57356045 |
| 128 | MP0008873_increased_physiological_sensi | 0.57094430 |
| 129 | MP0008874_decreased_physiological_sensi | 0.56675926 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.56511759 |
| 131 | MP0001958_emphysema | 0.55252846 |
| 132 | MP0000477_abnormal_intestine_morphology | 0.54699573 |
| 133 | MP0000013_abnormal_adipose_tissue | 0.53261196 |
| 134 | MP0003186_abnormal_redox_activity | 0.52309885 |
| 135 | MP0001191_abnormal_skin_condition | 0.51886020 |
| 136 | MP0001881_abnormal_mammary_gland | 0.50667729 |
| 137 | MP0009763_increased_sensitivity_to | 0.49954468 |
| 138 | MP0003091_abnormal_cell_migration | 0.49608768 |
| 139 | MP0000604_amyloidosis | 0.48603898 |
| 140 | MP0000350_abnormal_cell_proliferation | 0.48549567 |
| 141 | MP0002873_normal_phenotype | 0.48023385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.44938392 |
| 2 | Prostate neoplasm (HP:0100787) | 9.43811393 |
| 3 | Abnormality of B cell number (HP:0010975) | 8.76574726 |
| 4 | B lymphocytopenia (HP:0010976) | 8.76574726 |
| 5 | Colitis (HP:0002583) | 7.25972819 |
| 6 | Recurrent sinusitis (HP:0011108) | 6.72216847 |
| 7 | Cellulitis (HP:0100658) | 6.57903825 |
| 8 | Recurrent bronchitis (HP:0002837) | 6.17127621 |
| 9 | Papilloma (HP:0012740) | 6.13516094 |
| 10 | Verrucae (HP:0200043) | 6.13516094 |
| 11 | Abnormality of macrophages (HP:0004311) | 5.93859110 |
| 12 | Recurrent viral infections (HP:0004429) | 5.85759251 |
| 13 | Abnormality of the prostate (HP:0008775) | 5.85650208 |
| 14 | Inflammation of the large intestine (HP:0002037) | 5.37504107 |
| 15 | IgM deficiency (HP:0002850) | 5.35797903 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 5.35135923 |
| 17 | Gastrointestinal inflammation (HP:0004386) | 5.18028075 |
| 18 | Gastrointestinal stroma tumor (HP:0100723) | 5.07433817 |
| 19 | Meningitis (HP:0001287) | 4.85937544 |
| 20 | Recurrent pneumonia (HP:0006532) | 4.52502624 |
| 21 | Chronic otitis media (HP:0000389) | 4.16995657 |
| 22 | Osteomyelitis (HP:0002754) | 3.98876400 |
| 23 | Panhypogammaglobulinemia (HP:0003139) | 3.83936532 |
| 24 | Recurrent otitis media (HP:0000403) | 3.76975426 |
| 25 | Chronic sinusitis (HP:0011109) | 3.72252092 |
| 26 | Thyroiditis (HP:0100646) | 3.70048254 |
| 27 | Recurrent lower respiratory tract infections (HP:0002783) | 3.67933704 |
| 28 | Bronchitis (HP:0012387) | 3.50329077 |
| 29 | Abnormality of complement system (HP:0005339) | 3.50143761 |
| 30 | Hyperactive renin-angiotensin system (HP:0000841) | 3.44899525 |
| 31 | Abnormality of male internal genitalia (HP:0000022) | 3.42075686 |
| 32 | Sepsis (HP:0100806) | 3.38828175 |
| 33 | Glomerulonephritis (HP:0000099) | 3.38321900 |
| 34 | Emphysema (HP:0002097) | 3.31427230 |
| 35 | Complement deficiency (HP:0004431) | 3.23797479 |
| 36 | Alopecia of scalp (HP:0002293) | 3.14663208 |
| 37 | IgG deficiency (HP:0004315) | 3.09699808 |
| 38 | Recurrent fungal infections (HP:0002841) | 3.07564496 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 3.05618840 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.05332983 |
| 41 | IgA deficiency (HP:0002720) | 3.03859323 |
| 42 | Skin rash (HP:0000988) | 2.97924247 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.94562967 |
| 44 | Neoplasm of the lung (HP:0100526) | 2.93445666 |
| 45 | Vasculitis (HP:0002633) | 2.84816243 |
| 46 | Right ventricular cardiomyopathy (HP:0011663) | 2.83409307 |
| 47 | Premature loss of primary teeth (HP:0006323) | 2.82941856 |
| 48 | Nephritis (HP:0000123) | 2.82059697 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.79939184 |
| 50 | Malnutrition (HP:0004395) | 2.79271290 |
| 51 | Urticaria (HP:0001025) | 2.73275037 |
| 52 | Abnormality of T cells (HP:0002843) | 2.73107443 |
| 53 | Restrictive lung disease (HP:0002091) | 2.71719730 |
| 54 | Lymphopenia (HP:0001888) | 2.69447273 |
| 55 | Recurrent abscess formation (HP:0002722) | 2.60467804 |
| 56 | Nasal polyposis (HP:0100582) | 2.58376728 |
| 57 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57205261 |
| 58 | Gingivitis (HP:0000230) | 2.56346422 |
| 59 | Neoplasm of the respiratory system (HP:0100606) | 2.53756606 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.50633624 |
| 61 | Orchitis (HP:0100796) | 2.50464981 |
| 62 | T lymphocytopenia (HP:0005403) | 2.49089457 |
| 63 | Recurrent bacterial skin infections (HP:0005406) | 2.48665207 |
| 64 | Small epiphyses (HP:0010585) | 2.46276198 |
| 65 | Mitral stenosis (HP:0001718) | 2.43875463 |
| 66 | Hypermelanotic macule (HP:0001034) | 2.36988674 |
| 67 | Hemoptysis (HP:0002105) | 2.36056801 |
| 68 | Autoimmune hemolytic anemia (HP:0001890) | 2.32792825 |
| 69 | Fragile skin (HP:0001030) | 2.32532619 |
| 70 | Recurrent skin infections (HP:0001581) | 2.29320922 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.26897037 |
| 72 | Thick nail (HP:0001805) | 2.25558078 |
| 73 | Hypoplasia of the thymus (HP:0000778) | 2.24556745 |
| 74 | Skin ulcer (HP:0200042) | 2.23555535 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.19378953 |
| 76 | Bronchiectasis (HP:0002110) | 2.15148503 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.14480267 |
| 78 | Metaphyseal cupping (HP:0003021) | 2.13349700 |
| 79 | Polycythemia (HP:0001901) | 2.13075391 |
| 80 | Neutropenia (HP:0001875) | 2.12657133 |
| 81 | Peritonitis (HP:0002586) | 2.09458162 |
| 82 | Atrophic scars (HP:0001075) | 2.08541990 |
| 83 | Hematochezia (HP:0002573) | 2.07775855 |
| 84 | Retrobulbar optic neuritis (HP:0100654) | 2.06190837 |
| 85 | Optic neuritis (HP:0100653) | 2.06190837 |
| 86 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04842246 |
| 87 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04842246 |
| 88 | Aortic dissection (HP:0002647) | 2.01269583 |
| 89 | Ankyloglossia (HP:0010296) | 2.00156877 |
| 90 | Osteolytic defects of the hand bones (HP:0009699) | 1.99018618 |
| 91 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.99018618 |
| 92 | Increased IgE level (HP:0003212) | 1.98665081 |
| 93 | Decreased circulating renin level (HP:0003351) | 1.97880252 |
| 94 | Keratoconjunctivitis sicca (HP:0001097) | 1.97427230 |
| 95 | Flat acetabular roof (HP:0003180) | 1.95654705 |
| 96 | Abnormal hair laboratory examination (HP:0003328) | 1.95451978 |
| 97 | Villous atrophy (HP:0011473) | 1.95094854 |
| 98 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.95094854 |
| 99 | Persistence of primary teeth (HP:0006335) | 1.95075415 |
| 100 | Eosinophilia (HP:0001880) | 1.93218569 |
| 101 | Pulmonary infiltrates (HP:0002113) | 1.93212308 |
| 102 | Macroorchidism (HP:0000053) | 1.90688388 |
| 103 | Abnormality of nail color (HP:0100643) | 1.90439020 |
| 104 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.90368201 |
| 105 | Thrombocytosis (HP:0001894) | 1.89705069 |
| 106 | Palmoplantar hyperkeratosis (HP:0000972) | 1.89213775 |
| 107 | Mediastinal lymphadenopathy (HP:0100721) | 1.88610132 |
| 108 | Viral hepatitis (HP:0006562) | 1.88368209 |
| 109 | Pili torti (HP:0003777) | 1.86539979 |
| 110 | Combined immunodeficiency (HP:0005387) | 1.86446084 |
| 111 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.86180788 |
| 112 | Erythema (HP:0010783) | 1.85671119 |
| 113 | Gingival bleeding (HP:0000225) | 1.84955899 |
| 114 | Severe combined immunodeficiency (HP:0004430) | 1.84307257 |
| 115 | Myositis (HP:0100614) | 1.83629695 |
| 116 | Eczematoid dermatitis (HP:0000976) | 1.79428186 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 1.79319004 |
| 118 | Abnormal foot bone ossification (HP:0010675) | 1.76272597 |
| 119 | Lymphoma (HP:0002665) | 1.74632629 |
| 120 | Leukopenia (HP:0001882) | 1.72341598 |
| 121 | Arthralgia (HP:0002829) | 1.67043481 |
| 122 | Acrocyanosis (HP:0001063) | 1.65632234 |
| 123 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.65580087 |
| 124 | Pustule (HP:0200039) | 1.62359763 |
| 125 | Mucosal telangiectasiae (HP:0100579) | 1.60920744 |
| 126 | Papilledema (HP:0001085) | 1.60794944 |
| 127 | Obstructive lung disease (HP:0006536) | 1.57960637 |
| 128 | Chronic obstructive pulmonary disease (HP:0006510) | 1.57960637 |
| 129 | Dehydration (HP:0001944) | 1.55853186 |
| 130 | Flattened epiphyses (HP:0003071) | 1.55465375 |
| 131 | Abnormality of eosinophils (HP:0001879) | 1.55041759 |
| 132 | Teleangiectasia of the skin (HP:0100585) | 1.46367003 |
| 133 | Spontaneous hematomas (HP:0007420) | 1.45692565 |
| 134 | Granulocytopenia (HP:0001913) | 1.44428064 |
| 135 | Prominent nose (HP:0000448) | 1.44199802 |
| 136 | Spondylolisthesis (HP:0003302) | 1.40712890 |
| 137 | Periodontitis (HP:0000704) | 1.38515779 |
| 138 | Hypergammaglobulinemia (HP:0010702) | 1.37325560 |
| 139 | Encephalitis (HP:0002383) | 1.35990409 |
| 140 | Leukocytosis (HP:0001974) | 1.34752024 |
| 141 | Abnormality of the intrinsic pathway (HP:0010989) | 1.34452653 |
| 142 | Premature skin wrinkling (HP:0100678) | 1.33570598 |
| 143 | Abnormality of the common coagulation pathway (HP:0010990) | 1.33455098 |
| 144 | Ulnar bowing (HP:0003031) | 1.33432111 |
| 145 | Basal cell carcinoma (HP:0002671) | 1.31262409 |
| 146 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.30869375 |
| 147 | Limb hypertonia (HP:0002509) | 1.29574251 |
| 148 | Abnormal tarsal ossification (HP:0008369) | 1.29515133 |
| 149 | Xerostomia (HP:0000217) | 1.29315551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.39428327 |
| 2 | MAP4K1 | 4.94919177 |
| 3 | TAOK3 | 3.39782816 |
| 4 | MAP3K10 | 3.18097099 |
| 5 | RIPK4 | 2.97960749 |
| 6 | GRK6 | 2.96145058 |
| 7 | TESK2 | 2.89359614 |
| 8 | MST1R | 2.86477270 |
| 9 | TYK2 | 2.74611689 |
| 10 | RIPK1 | 2.43287379 |
| 11 | SYK | 2.38146505 |
| 12 | EPHA3 | 2.36379097 |
| 13 | SIK2 | 2.29457131 |
| 14 | PRPF4B | 2.20616318 |
| 15 | CSF1R | 2.12935436 |
| 16 | KIT | 2.12675649 |
| 17 | PIK3CA | 1.98605848 |
| 18 | BLK | 1.92361419 |
| 19 | TXK | 1.89106763 |
| 20 | BTK | 1.82799023 |
| 21 | MAP3K14 | 1.78663449 |
| 22 | BMPR2 | 1.77825127 |
| 23 | EIF2AK3 | 1.74599965 |
| 24 | JAK1 | 1.74239187 |
| 25 | NME2 | 1.59374996 |
| 26 | MAP3K13 | 1.59002630 |
| 27 | ITK | 1.52760593 |
| 28 | PDGFRA | 1.46687252 |
| 29 | GRK1 | 1.45057743 |
| 30 | IRAK3 | 1.43607336 |
| 31 | IRAK1 | 1.41978058 |
| 32 | STK10 | 1.41490068 |
| 33 | IRAK4 | 1.38904788 |
| 34 | HIPK2 | 1.38358906 |
| 35 | FGFR3 | 1.36020285 |
| 36 | MAP3K3 | 1.34146163 |
| 37 | LYN | 1.30174913 |
| 38 | FER | 1.28832642 |
| 39 | MAP3K1 | 1.28427880 |
| 40 | EEF2K | 1.27937625 |
| 41 | HCK | 1.27428386 |
| 42 | JAK3 | 1.26244485 |
| 43 | PRKCH | 1.25962875 |
| 44 | TBK1 | 1.24167479 |
| 45 | EPHA2 | 1.21416006 |
| 46 | PIK3CG | 1.17049735 |
| 47 | TGFBR1 | 1.16429648 |
| 48 | IKBKE | 1.16140223 |
| 49 | CDK12 | 1.15467075 |
| 50 | TGFBR2 | 1.11766418 |
| 51 | FGFR4 | 1.11699872 |
| 52 | MET | 1.10186557 |
| 53 | PIM1 | 1.09888437 |
| 54 | IKBKB | 1.08401577 |
| 55 | FES | 1.07068590 |
| 56 | LRRK2 | 1.04636910 |
| 57 | NEK2 | 1.02474768 |
| 58 | MAP2K3 | 1.02060174 |
| 59 | SIK3 | 1.00418008 |
| 60 | CLK1 | 0.98768315 |
| 61 | DDR2 | 0.96621378 |
| 62 | STK24 | 0.95275890 |
| 63 | LMTK2 | 0.87616439 |
| 64 | MAP3K6 | 0.87178607 |
| 65 | PRKCQ | 0.86893672 |
| 66 | TAOK1 | 0.85494962 |
| 67 | NEK9 | 0.83504004 |
| 68 | LCK | 0.83146151 |
| 69 | GRK5 | 0.82315687 |
| 70 | TEC | 0.79396609 |
| 71 | ALK | 0.78183326 |
| 72 | NLK | 0.77969155 |
| 73 | TRIB3 | 0.73747734 |
| 74 | CSK | 0.73474411 |
| 75 | MAPK7 | 0.73301164 |
| 76 | RET | 0.72951286 |
| 77 | CDK9 | 0.72496455 |
| 78 | ACVR1B | 0.71983537 |
| 79 | EPHB2 | 0.71331382 |
| 80 | FGR | 0.71292116 |
| 81 | YES1 | 0.71162130 |
| 82 | SIK1 | 0.70364072 |
| 83 | BMX | 0.70337888 |
| 84 | FLT3 | 0.70308885 |
| 85 | PRKD1 | 0.68076073 |
| 86 | PDGFRB | 0.65617397 |
| 87 | FRK | 0.64527535 |
| 88 | CDK4 | 0.62585023 |
| 89 | MATK | 0.61067714 |
| 90 | MAP3K7 | 0.58566105 |
| 91 | PDK1 | 0.58113030 |
| 92 | MAP3K9 | 0.55627221 |
| 93 | MYLK | 0.55420479 |
| 94 | MAPK12 | 0.54263242 |
| 95 | PRKD2 | 0.54024283 |
| 96 | BCKDK | 0.53200441 |
| 97 | MST4 | 0.51505005 |
| 98 | EPHB1 | 0.51461453 |
| 99 | FGFR2 | 0.51273852 |
| 100 | FYN | 0.50854373 |
| 101 | MAPK4 | 0.49830465 |
| 102 | CAMK1G | 0.49599637 |
| 103 | JAK2 | 0.49116689 |
| 104 | PDPK1 | 0.48827510 |
| 105 | PDK2 | 0.47828085 |
| 106 | CHUK | 0.47529318 |
| 107 | IGF1R | 0.47388643 |
| 108 | BRD4 | 0.46725138 |
| 109 | CDK6 | 0.45796126 |
| 110 | SGK3 | 0.44963625 |
| 111 | PKN1 | 0.42955503 |
| 112 | TTN | 0.42801527 |
| 113 | NUAK1 | 0.42585150 |
| 114 | TAOK2 | 0.41935553 |
| 115 | PAK4 | 0.39917520 |
| 116 | WNK1 | 0.39559008 |
| 117 | MAPKAPK3 | 0.39497931 |
| 118 | PKN2 | 0.39424379 |
| 119 | MAPK11 | 0.37478112 |
| 120 | KSR2 | 0.37240199 |
| 121 | STK4 | 0.36496386 |
| 122 | PRKG2 | 0.36129931 |
| 123 | UHMK1 | 0.35210005 |
| 124 | ADRBK2 | 0.34368158 |
| 125 | MAP3K11 | 0.34347199 |
| 126 | MAP3K2 | 0.34063339 |
| 127 | PRKCD | 0.32841256 |
| 128 | ABL1 | 0.32763467 |
| 129 | MARK3 | 0.32375957 |
| 130 | TIE1 | 0.31615890 |
| 131 | MAPK3 | 0.30931342 |
| 132 | IRAK2 | 0.30016417 |
| 133 | MAP3K8 | 0.29123801 |
| 134 | EGFR | 0.28277421 |
| 135 | ZAP70 | 0.27664338 |
| 136 | INSR | 0.26773288 |
| 137 | RPS6KB2 | 0.24048952 |
| 138 | GSK3A | 0.23561940 |
| 139 | PRKAA1 | 0.23532831 |
| 140 | PTK6 | 0.22468364 |
| 141 | MAPKAPK2 | 0.20894178 |
| 142 | DMPK | 0.20845335 |
| 143 | MARK2 | 0.20795023 |
| 144 | CDC42BPA | 0.20144607 |
| 145 | CSNK1A1L | 0.19067305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.96320780 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.40954312 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.53076551 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.32841241 |
| 5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 3.01803470 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.76218006 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.69371042 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.65641089 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13705671 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.98318652 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93585388 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.83837503 |
| 13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.79428812 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.71170263 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67464072 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.62637431 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61254179 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.60185897 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.47305652 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.46778753 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41249723 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37160322 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.36988285 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36801385 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31039843 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.27121023 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.21877974 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21749029 |
| 29 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.13404730 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08773471 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.06792114 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05939186 |
| 33 | Amoebiasis_Homo sapiens_hsa05146 | 1.05026466 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03991336 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.00165221 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99891757 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98943835 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 0.96396258 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91947013 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91708241 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89542934 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87187784 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 0.85566913 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84849369 |
| 45 | Malaria_Homo sapiens_hsa05144 | 0.83719438 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79122871 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78741484 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78031203 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74509789 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.73694871 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73072354 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.72871683 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72020853 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71661758 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71398361 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70013246 |
| 57 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69598724 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.67727318 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.67659108 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.67220764 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66279472 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.65751450 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64539842 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64241288 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63726287 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63556070 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61370462 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61334095 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60286424 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60076776 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59779928 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.59300030 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59257603 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58977570 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.58747123 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58690022 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58276931 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57842360 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57009431 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56262926 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.55866147 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.54541460 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.54312677 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52862403 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52213893 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.51999097 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51856015 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51230099 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50274736 |
| 90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49629868 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49130227 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47770811 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47676820 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.47612194 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46981117 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46332004 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45980042 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45645584 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.42274137 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41039064 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40336799 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39151908 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37096622 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36848107 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36468884 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35575995 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35128396 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34655710 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33581211 |
| 110 | Legionellosis_Homo sapiens_hsa05134 | 0.33540408 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.32495980 |
| 112 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32334003 |
| 113 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31848972 |
| 114 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.31648512 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.31588569 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30773462 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30723456 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29642542 |
| 119 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.29558510 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.29323854 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28985880 |
| 122 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.28200167 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.27070876 |
| 124 | DNA replication_Homo sapiens_hsa03030 | 0.26568746 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25090795 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22938829 |
| 127 | Shigellosis_Homo sapiens_hsa05131 | 0.22859229 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22746943 |
| 129 | Prostate cancer_Homo sapiens_hsa05215 | 0.19790121 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.18303470 |
| 131 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.18047560 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17721766 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17393652 |
| 134 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.16961966 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14835536 |

